Welcome to Labeled Immunoassays and Clinical Medicine website!

Relationship Between the Levels of Serum CysC, RBP and Urinary NAG Changes and the Development of Diabetic Nephropathy in Diabetic Patients with Renal Microvascular Lesions

Expand
  • Department of Clinical Laboratory, Beijing Renhe Hospital, Beijing 102600, China

Received date: 2015-01-29

  Revised date: 2015-04-14

  Online published: 2015-09-16

Abstract

Abstract: Objective To explore the relationship between the levels of serum cystatin C (CysC), retinol binding protein (RBP) and urinary N- acetyl beta -D Glucosaminidase (NAG) changes and the severity of diabetic nephropathy in diabetic patients with renal microvascular lesions. Methods 30 cases of type 2 diabetic patients with nephropathy (urinary albumin<14.29mg/L) as group A, 30 cases of type 2 diabetic patients with nephropathy (urinary albumin≥ 14.29mg/L) as group B, 30 cases of type 2 diabetic nephropathy uremia patients as group C and 30 normal subjects as group D were involved in this study. The serum levels of CysC, RBP and urine NAG in all groups were determined. Results There were significantly difference on the levels of serum CysC, RBP and urine NAG between four groups (P <0.01). The levels of serum CysC, RBP and urine NAG in group A, group B and group C were significantly higher than those in group D (P <0.05). The levels of serum CysC, RBP and urine NAG in group A and group B were significantly lower than those in group C (P <0.05). The levels of serum CysC, RBP and urine NAG in group A were significantly lower than that of in group B (P <0.05). Conclusion The levels of serum CysC, RBP and urinary NAG in diabetic patients with renal microvascular lesions show an increase tendency as the severity of diabetic nephropathy increasing.

Cite this article

LI Fen-e, KANG Xi-xiong . Relationship Between the Levels of Serum CysC, RBP and Urinary NAG Changes and the Development of Diabetic Nephropathy in Diabetic Patients with Renal Microvascular Lesions[J]. Labeled Immunoassays and Clinical Medicine, 2015 , 22(6) : 522 . DOI: 10.11748/bjmy.issn.1006-1703.2015.06.015

Options
Outlines

/